High Blood Pressure (Hypertension): Guidelines, Risks & Management
Hypertension is a leading modifiable risk factor for cardiovascular disease. Per ACC/AHA 2017 guidelines (endorsed by AHA), blood pressure categories are:
Blood Pressure Classification (Adults)
| Category | Systolic (mmHg) | Diastolic (mmHg) |
|---|---|---|
| Normal | <120 | <80 |
| Elevated | 120–129 | <80 |
| Stage 1 HTN | 130–139 | 80–89 |
| Stage 2 HTN | ≥140 | ≥90 |
| Hypertensive Crisis | >180 | >120 |
Major Health Risks of Uncontrolled HTN
- Stroke (ischemic & hemorrhagic)—#1 risk factor
- Myocardial infarction & heart failure
- Chronic kidney disease & failure
- Retinopathy & vision loss
- Peripheral artery disease
- Cognitive decline & dementia
- Sexual dysfunction (erectile dysfunction, female sexual dysfunction)
- Aortic aneurysm/dissection
Key Risk Factors
- Non-modifiable: Age, family history, race (Black adults higher prevalence), chronic kidney disease.
- Modifiable: Obesity, physical inactivity, high sodium/low potassium diet, excessive alcohol, smoking, stress, sleep apnea, diabetes, dyslipidemia.
Lifestyle Modifications (First-Line for All Stages)
| Intervention | Target | Expected SBP Reduction |
|---|---|---|
| DASH diet | Fruits, vegetables, low-fat dairy, whole grains, low sodium | –11 mmHg |
| Sodium restriction | <1,500 mg/day (ideal); <2,300 mg minimum | –5 to –6 mmHg |
| Potassium increase | 3,500–5,000 mg/day (food sources) | –4 to –5 mmHg |
| Weight loss | BMI 18.5–24.9; waist <40" (M), <35" (F) | –1 mmHg per kg lost |
| Physical activity | ≥150 min/wk moderate or 75 min/wk vigorous + resistance 2×/wk | –5 to –8 mmHg |
| Alcohol moderation | ≤2 drinks/day (M), ≤1 (F) | –4 mmHg |
| Smoking cessation | Complete | CV risk reduction > BP effect |
| Stress management | Meditation, CBT, biofeedback, adequate sleep | Variable |
Pharmacologic Treatment
Indicated for:
- Stage 1 HTN + ASCVD or 10-year ASCVD risk ≥10%
- Stage 2 HTN
- Any stage with diabetes, CKD, heart failure
First-Line Drug Classes
- Thiazide/thiazide-like diuretics (chlorthalidone, indapamide)
- ACE inhibitors (lisinopril, ramipril)
- ARBs (losartan, valsartan)
- Dihydropyridine CCBs (amlodipine)
Combination therapy often needed; single-pill combinations improve adherence.
Monitoring & Goals
- Home BP monitoring: Validated device, proper technique, morning/evening readings, share with clinician.
- Target: <130/80 mmHg for most adults (individualize for frailty, orthostasis, comorbidities).
- Follow-up: Monthly until controlled, then 3–6 months.
Hypertension is a silent killer—often asymptomatic until complications arise. Regular screening, lifestyle change, and appropriate medication save lives.
Hypertension - Related Articles
- Hydrochlorothiazide: Uses, Side Effects & Dosage
- Managing Isolated Systolic Hypertension: Lifestyle Strategies & Risk Reduction
- Lisinopril Side Effects: What You Need to Know
- Understanding Temporary High Blood Pressure: Causes, Risks & Management
- Understanding High Blood Pressure Medication: Side Effects & Management
- Amlodipine Side Effects: What You Need to Know
- Hypertension's Effects on the Heart: LVH, Fibrosis, and Heart Failure
